Development of COVID-19 vaccine


Development of nanoparticle-based dengue DNA vaccine


We have been working on HIV DNA vaccine

HDM Allergy

Development of vaccines for prevention and treatment of HDM allergy


Development of subunit vaccines against leptospirosis

Center of Excellence in Vaccine Research and Development,
Chulalongkorn University (Chula VRC)

Chula VRC was formally established in 2017 under the supervision of Professor Kiat Ruxrungtham. We consists of faculty staff and researchers with common interest in vaccine research and development to work together and share their knowledge and experience leading to the strength of the team. We focuses not only on vaccines against infectious diseases, such as HIV infection, dengue fever, leptospirosis, and emerging infections including novel corona virus disease (COVID-19) but also vaccines against non-infectious diseases including house dust mite allergy.

Key Contact Persons

Latest News & Events

May 25, 2024
From: Health Policy Watch / By Petro Terblanche, Jerome Kim, Rajinder Suri & Padmashr
Posted in News | Tags: , ,
April 28, 2024
April 17, 2024

From: Vaccine Insights Tuck Seng Wong, Kiat Ruxrungtham Vaccine security and self-relianc

March 21, 2024

The mRNA Technology Transfer Programme organized on 18 March 2024 in Singapore the 4th Sc

Posted in News
December 22, 2023


November 6, 2023

From: Department of Chemical and Biological Engineering, University of Sheffield Professo

October 9, 2023

Organized by Chula Vaccine and Research Center (Chula VRC)

October 6, 2023

Congratulations to Drew Weissman and Katalin Kariko for the Nobel Prize in Physiology or

September 21, 2023

From: The Independent Panel for Pandemic Preparedness and Response Statement of the Right

Posted in News | Tags: